|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|
| Operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization expense | |
| Non-cash interest expense | |
| Stock-based compensation expense | |
| Change in fair value of contingent consideration | |
| Deferred tax benefit | |
| Non-cash lease expense | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses and other current assets | |
| Accounts payable | |
| Accrued expenses and other liabilities | |
| Due to related parties | |
| Payment of contingent consideration | |
| Deferred tax credits | |
| Net cash used in operating activities | |
| Investing activities: | |
| Purchase of property and equipment | |
| Net cash used in investing activities | |
| Financing activities: | |
| Proceeds from the sale of convertible preferred stock | |
| Payment of financing costs related to sale of convertible preferred stock | |
| Payment of deferred financing costs related to initial public offering | |
| Settlement of deferred payment related to the acquisition of Zihipp, Ltd. | |
| Payment of contingent consideration | |
| Net cash provided by financing activities | |
| Effect of exchange rates on cash and cash equivalents | |
| Net increase in cash and cash equivalents | |
| Cash and cash equivalents at the beginning of year | |
| Cash and cash equivalents at the end of year | |
| Supplemental non-cash financing activities: | |
| Deferred financing costs within accounts payable and accrued expenses | |
| Issuance of related party note to settle contingent consideration | |
| Cash paid for interest | |
| Operating lease right-of-use asset exchanged for operating lease liability |
Loading...
